Unknown NA INTERVENTIONAL 7-arm NCT06021002

Nasal Immune Challenge Study

Sponsor: Cambridge University Hospitals NHS Foundation Trust

Conditions Asthma Innate Inflammatory Response Nasal Allergy

Updated 4 times since 2023 Last updated: Aug 25, 2023 Started: Aug 9, 2022 Primary completion: Sep 30, 2024 Completion: Sep 30, 2024

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT06021002, this NA trial focuses on Asthma and Innate Inflammatory Response and remains ongoing. Sponsored by Cambridge University Hospitals NHS Foundation Trust, it has been updated 4 times since 2022, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

4 versions recorded

Oct 2025 — Present [monthly]

Unknown NA

Status: Recruiting → Unknown
Sep 2024 — Oct 2025 [monthly]

Recruiting NA
Jul 2024 — Sep 2024 [monthly]

Recruiting NA
Oct 2023 — Jul 2024 [monthly]

Recruiting NA

First recorded

Aug 2022

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Cambridge University Hospitals NHS Foundation Trust

Data source: Cambridge University Hospitals NHS Foundation Trust

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Cambridge, United Kingdom